Follow The Filings

CHRN ChronoScale

ChronoScale earnings company data as of 4:47 AM ET 10/7

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 27 Oct EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by CHRN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CHRN insider trades
  • $1.2M bought by 3 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Jason C Jones COO
    Buy
    $15K 1,308 shares at $11.85 +42% to stake
    Traded Mar 16 Filed Mar 20
  2. Daniel Asher 10% owner
    Buy
    $191K 15,540 shares at $12.30 +6.1% to stake
    Traded Feb 19 Filed Feb 20
  3. Daniel Asher 10% owner
    Buy
    $12K 1,200 shares at $9.60 +0.5% to stake
    Traded Feb 19 Filed Feb 19
  4. Daniel Asher 10% owner
    Buy
    $970K 102,029 shares at $9.51 +65% to stake
    Traded Feb 6–13 Filed Feb 17

Also filed in the last 12 months, not counted as buying or selling: 15 stock grants and 6 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
DEFA14A
8-K 2.02,9.01
10-Q
8-K 5.02
8-K 5.02,5.03,7.01,9.01
DEF 14A
DEFA14A
8-K 1.01,9.01
8-K 7.01,8.01,9.01
10-K
8-K 5.02,9.01
8-K 5.02,8.01,9.01
8-K/A 8.01,9.01
SCHEDULE 13D/A —
8-K 1.01,2.03,9.01
8-K 2.05
8-K/A 5.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13D —
8-K/A 1.01,2.01,2.02,3.02,3.03,4.01,5.01,5.02,5.03,9.01
8-K 1.01,3.02,3.03,5.03,9.01
10-Q FORM 10-Q
10-K/A FORM 10-K/A
SCHEDULE 13G —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.